Hence, SIRT1 activation (and NAD+ replenishment) may not only activate eNOS but will also inhibit endothelial cell senescence, atherosclerosis and inflammatory response in the lung [23,44,45]. The gene discussed is SIRT1; the disease is atherosclerosis.